Radiosynthesis of 11C-Levetiracetam: A Potential Marker for PET Imaging of SV2A Expression
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The multistep preparation of (11)C-levetiracetam ((11)C-LEV) was carried out by a one-pot radiosynthesis with 8.3 ± 1.6% (n = 8) radiochemical yield in 50 ± 5.0 min. Briefly, the propionaldehyde was converted to propan-1-imine in situ as labeling precursor by incubation with ammonia. Without further separation, the imine was reacted with (11)C-HCN to form (11)C-aminonitrile. This crude was then reacted with 4-chlorobutyryl chloride and followed by hydrolysis to yield (11)C-LEV after purification by chiral high-performance liquid chromatography (HPLC). Both the radiochemical and enantiomeric purities of (11)C-LEV were >98%.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the first attempt to develop a SV2A-PET radioligand was [ 11 C]levetiracetam”
From Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression (2025) · cites this paper as [108]
Citations
Cites
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
Lynch, B. A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S. M., Matagne, A., & Fuks, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308208101 · Cited by 1,610
Sanchez, P. E., Zhu, L., Verret, L., Vossel, K. A., Orr, A. G., Cirrito, J. R., Devidze, N., Ho, K., Yu, G.-Q., Palop, J. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121081109 · Cited by 638
Barton, D. H. R., Crich, D., & Motherwell, W. B. (1985) · Tetrahedron · doi:10.1016/s0040-4020(01)97173-x · Cited by 537
Levetiracetam: a review of its use in epilepsy.
Lyseng-Williamson, K. A. (2011) · PubMed · doi:10.2165/11204490-000000000-00000 · Cited by 194
The Role of Imaging in Proof of Concept for CNS Drug Discovery and Development
Wong, D. F., Tauscher, J., & Gründer, G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.166 · Cited by 166
Neves, A. A., & Brindle, K. M. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.114264 · Cited by 158
Surges, R., Volynski, K. E., & Walker, M. C. (2008) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285608094212 · Cited by 129
Synaptic vesicle protein 2A: basic facts and role in synaptic function
Mendoza‐Torreblanca, J. G., Vanoye‐Carlo, A., Phillips‐Farfán, B. V., Carmona‐Aparicio, L., & Gómez‐Lira, G. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12360 · Cited by 124
11CO2 fixation: a renaissance in PET radiochemistry
Rotstein, B. H., Liang, S. H., Holland, J. P., Collier, T. L., Hooker, J. M., Wilson, A. A., & Vasdev, N. (2013) · Chemical Communications · doi:10.1039/c3cc42236d · Cited by 98
Evaluation of18F-UCB-H as a Novel PET Tracer for Synaptic Vesicle Protein 2A in the Brain
Warnock, G. I., Aerts, J., Bahri, M. A., Bretin, F., Lemaire, C., Giacomelli, F., Mievis, F., Mestdagh, N., Buchanan, T., Valade, A., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.136143 · Cited by 85
Pegloticase: In Treatment-Refractory Chronic Gout
Lyseng-Williamson, K. A. (2011) · Drugs · doi:10.2165/11202830-000000000-00000 · Cited by 76
Mercier, J., Archen, L., Bollu, V., Carré, S., Evrard, Y., Jnoff, E., Kenda, B., Lallemand, B., Michel, P., Montel, F., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201300482 · Cited by 68
A new highly chemoselective isomerization of allylamides
Neugnot, B., Cintrat, J., & Rousseau, B. (2004) · Tetrahedron · doi:10.1016/j.tet.2004.03.004 · Cited by 62
Levetiracetam for managing neurologic and psychiatric disorders
Farooq, M. U., Bhatt, A., Majid, A., Gupta, R., Khasnis, A., & Kassab, M. Y. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070607 · Cited by 60
Isomerization of Allyl Ethers Initiated by Lithium Diisopropylamide
Su, C., & Williard, P. G. (2010) · Organic Letters · doi:10.1021/ol102029u · Cited by 60
A synthesis of levetiracetam based on (S)-N-phenylpantolactam as a chiral auxiliary
Boschi, F., Camps, P., Franchini, M. C., Muñoz‐Torrero, D., Ricci, A., & Sánchez, L. (2005) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2005.10.014 · Cited by 50
Saricicek, A., Maloney, K., Muralidharan, A., Ruf, B., Blumberg, H. P., Sanacora, G., Lorberg, B., Pittman, B., & Bhagwagar, Z. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05659gre · Cited by 50
Organische Gas‐Festkörper‐Reaktionen mit Stilbenen, Chalkonen und Enamiden
Kaupp, G., & Matthies, D. (1987) · Chemische Berichte · doi:10.1002/cber.19871201120 · Cited by 45
Preclinical radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H
Bretin, F., Warnock, G., Bahri, M. A., Aerts, J., Mestdagh, N., Buchanan, T., Valade, A., Mievis, F., Giacomelli, F., Lemaire, C., et al. (2013) · EJNMMI Research · doi:10.1186/2191-219x-3-35 · Cited by 43
Pharmacotherapeutics of Tourette Syndrome and Stereotypies in Autism
Rajapakse, T., & Pringsheim, T. M. (2010) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2010.10.008 · Cited by 37
Barriers to Clinical Translation with Diagnostic Drugs
Josephson, L., & Rudin, M. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.107615 · Cited by 27
Reaction of alkenes with hydrogen bromide in acetic acid. Polar addition via the Ad3 mechanism
Fahey, R. C., McPherson, C. A., & Smith, R. A. (1974) · Journal of the American Chemical Society · doi:10.1021/ja00821a029 · Cited by 26
Halldin, C., Schoeps, K., Stone‐Elander, S., & Wiesel, F.-A. (1987) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00256552 · Cited by 26
Levetiracetam as an alternative therapy for Tourette syndrome
Granero, M. Á. M. (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6371 · Cited by 23
Automated no-carrier-added synthesis of [1-11C]-labeled d- and l-enantiomers of lactic acid
Drandarov, K., Schubiger, P. A., & Westera, G. (2006) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2006.05.013 · Cited by 18
Steroid synthesis. The modified hunsdiecker degradation of bile acids and related compounds
Knapp, F. F. (1979) · Steroids · doi:10.1016/0039-128x(79)90001-1 · Cited by 5
Hildenbrand, S., Baqi, Y., & Müller, C. E. (2011) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.1942 · Cited by 5
Research works printed but not linked: 1
- Sanchez P. E., 2012, Proc. Natl. Acad. Sci. U.S.A., 109, E2895
Cited by
Nabulsi, N. B., Mercier, J., Holden, D., Carré, S., Najafzadeh, S., Vandergeten, M.-C., Lin, S.-F., Deo, A., Price, N., Wood, M., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.168179 · Cited by 296
“1) is feasible (10), it is likely that its affinity is too low and its brain penetration not sufficiently fast to perform well as a PET tracer.”
BackgroundFinnema, S. J., Nabulsi, N. B., Mercier, J., Lin, S.-F., Chen, M.-K., Matuskey, D., Gallezot, J.-D., Henry, S., Hannestad, J., Huang, Y., et al. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17724947 · Cited by 218
Rafiee, M., Konz, Z. M., Graaf, M. D., Koolman, H. F., & Stahl, S. S. (2018) · ACS Catalysis · doi:10.1021/acscatal.8b01640 · Cited by 186
Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond
Löscher, W., Gillard, M., Sands, Z. A., Kaminski, R. M., & Klitgaard, H. (2016) · CNS Drugs · doi:10.1007/s40263-016-0384-x · Cited by 184
PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases
Cai, Z., Li, S., Matuskey, D., Nabulsi, N., & Huang, Y. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2018.07.038 · Cited by 131
Metadata
- Authors
- Cai, H., Mangner, T. J., Muzik, O., Wang, M.-W., Chugani, D. C., & Chugani, H. T.
- Affiliations
- Detroit Medical Center (US)
- Corresponding author
- Cai, Hancheng
- Venue
- ACS Medicinal Chemistry Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2014-08-27
- Volume
- 5
- Issue
- 10
- Pages
- 1152-1155
- ISSN
- 1948-5875 (ISSN-L)
- PMC
- PMC4190623
- OpenAlex
- W2322216374
- Cited by
- 58
- References
- 27
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 8 · 2023: 4 · 2022: 6 · 2021: 5 · 2020: 6 · 2019: 7 · 2018: 4 · 2017: 7 · 2016: 4 · 2015: 1
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- ACS Medicinal Chemistry Letters (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wayne State University
- Children's Hospital of Michigan
- Institute of Chemistry, Chinese Academy of Sciences
- Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Chemical Reactions and Isotopes
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- radiotracer synthesis, one-pot synthesis, SV2A, positron emission tomography, carbon-11, aminonitriles, enantiomeric purity, chiral HPLC, propionaldehyde
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.